FindTrial
Sign In

Study of predictive blood investigations in stomach cancer

Role of Predictive and prognostic biomarkers in gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042256
Enrollment
200
Registered
2022-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C169- Malignant neoplasm of stomach, unspecified

Interventions

None listed

Sponsors

Jawaharlal institute of postgraduate medical education and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with age 18 years and above and Histopathology Proven Gastric Adenocarcinoma including Junctional (Gastro-esophageal junction) tumor with or without associated barretâ??s esophagus

Exclusion criteria

Exclusion criteria: - PATIENTS WHO HAVE ALREADY RECIEVED CHEMOTHERAPY FOR ADENOCARCINOMA OF STOMACH - PATIENTS WHO HAVE ALREADY UNDERGONE CURATIVE RESECTION FOR ADENOCARCINOMA STOMACH AND PRESENT WITH RECURRENCE

Design outcomes

Primary

MeasureTime frame
Recurrence rate of gastric cancerTimepoint: 6 month, 12 months and 24 months—

Secondary

MeasureTime frame
Mortality due to progressive disease, Overall survival rate and disease free survival rate with in the median follow up periodTimepoint: 2 years—

Countries

India

Contacts

Public ContactSuresh Kumar S

JIPMER, Puducherry

drsureshkumar08@gmail.com9788637893

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026